| # | Drug | Count |
|---|---|---|
| 0 | ADALIMUMAB | 3 |
| 1 | CLOPIDOGREL | 3 |
| 2 | FLUTICASONE PROPIONATE AND SALMETEROL | 3 |
| 3 | IBUPROFEN | 3 |
| 4 | LANSOPRAZOLE | 3 |
| 5 | METOPROLOL | 3 |
| 6 | METOPROLOL TARTRATE | 3 |
| 7 | MODAFINIL | 3 |
| 8 | ASPIRIN | 2 |
| 9 | ASPIRIN 325 MG | 2 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | DOPAMINE HYDROCHLORIDE | 1 | 0.0003 |
| 1 | DOBUTAMINE | 1 | 0.0003 |
| 2 | EFGARTIGIMOD ALFA | 1 | 0.0003 |
| 3 | TAFAMIDIS | 2 | 0.0002 |
| 4 | MODAFINIL | 3 | 0.0001 |
| 5 | ERGOCALCIFEROL | 2 | 0.0001 |
| 6 | BUSULFAN | 1 | 0.0001 |
| 7 | BENZONATATE | 1 | 0.0001 |
| 8 | ERYTHROMYCIN | 1 | 0.0001 |
| 9 | ECULIZUMAB | 2 | 0.0000 |
| # | Drug class | Count |
|---|---|---|
| 0 | Nonsteroidal Anti-inflammatory Drug [EPC] | 5 |
| 1 | Proton Pump Inhibitor [EPC] | 4 |
| 2 | beta-Adrenergic Blocker [EPC] | 4 |
| 3 | Interferon beta [EPC] | 3 |
| 4 | Sympathomimetic-like Agent [EPC] | 3 |
| 5 | Thiazide Diuretic [EPC] | 3 |
| 6 | Alkylating Drug [EPC] | 2 |
| 7 | Benzodiazepine [EPC] | 2 |
| 8 | Complement Inhibitor [EPC] | 2 |
| 9 | P2Y12 Platelet Inhibitor [EPC] | 2 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | 4-Hydroxyphenyl-Pyruvate Dioxygenase Inhibitor [EPC] | 1 | 0.0012 |
| 1 | Neonatal Fc Receptor Blocker [EPC] | 1 | 0.0002 |
| 2 | Chloride Channel Activator [EPC] | 1 | 0.0001 |
| 3 | Sympathomimetic-like Agent [EPC] | 3 | 0.0001 |
| 4 | Potassium-sparing Diuretic [EPC] | 1 | 0.0001 |
| 5 | Provitamin D2 Compound [EPC] | 2 | 0.0001 |
| 6 | Non-narcotic Antitussive [EPC] | 1 | 0.0001 |
| 7 | Cystic Fibrosis Transmembrane Conductance Regulator Potentiator [EPC] | 1 | 0.0001 |
| 8 | Bile Acid [EPC] | 1 | 0.0000 |
| 9 | Aluminum Complex [EPC] | 1 | 0.0000 |